Back to Newsroom

Cue’s CEO Ayub Khattak joins Lisa Ling on Season 2 of Johnson & Johnson’s COVID-19 Series: The Road to a Vaccine

October 20, 2020

San Diego, CA (October 20, 2020) – Cue’s CEO Ayub Khattak spoke with Lisa Ling as part of Johnson & Johnson’s The Road to a Vaccine series. During the segment, Ayub and Lisa discuss the lengthy turnaround time that many Americans have encountered during the pandemic with traditional PCR laboratory tests, and Cue’s ability to supply a highly-sensitive, molecular test that is fast, portable, and easy-to-use in point-of-care settings. Cue's recent public-private partnership with the DOD and HHS will enable the US Government to deploy 6 Million Cue COVID-19 Test to Americans, furthering access to fast, accurate molecular testing. He also notes that the company has partnered with the Biomedical Advanced Research Development Authority (BARDA), a division of HHS, since 2018 to develop a point-of-care Influenza test.

Ayub was joined by fellow panelists Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson, as well as Dr. Cato T. Laurencin, Professor at the University of Connecticut and Chief Executive Officer of the Connecticut Convergence Institute at the University of Connecticut. To view the full episode, please visit the Road to Vaccine webpage here.

Media Inquiries

Follow Us

Stay up to date on the latest from Cue